Chlorambucil
- TRADE NAMES: Chloraminophene; Leukeran (GSK); Linfolysin
- INDICATIONS: Chronic lymphocytic leukemia, lymphomas, carcinomas
- CLASS: Alkylating agent
- HALF-LIFE: 1.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Antineoplastics, Azathioprine, Bone marrow suppressants, Prednisone, Vaccines
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric